|Day's range||13.10 - 13.10|
Agilent Technologies' (A) second-quarter fiscal 2023 results reflect strength across LSAG and ACG segments.
What happened Shares of Agilent Technologies (NYSE: A) were sinking 7.9% lower as of 11:34 a.m. ET on Wednesday. The decline came after the life sciences company announced its fiscal 2023 second-quarter results following the market close on Tuesday.
Investing.com -- Stocks in focus in premarket trade on Wednesday, May 24th. Please refresh for updates.
Agilent (A) delivered earnings and revenue surprises of 0% and 2.97%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?
SANTA CLARA, Calif., May 23, 2023--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.72 billion for the second quarter ended April 30, 2023, an increase of 6.8% compared to the second quarter of 2022 and up 9.5% on a core(1) basis.
Investing.com - U.S. stock futures were trading slightly higher during Tuesday's evening deals, following a negative session among benchmark averages amid ongoing debt-ceiling negotiations and quarterly earnings results.
SANTA CLARA, Calif., May 22, 2023--Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in Q&A sessions at the Jefferies and Goldman Sachs healthcare conferences. Below are details of each session.
Agilent's (A) results for the fiscal second quarter are expected to reflect strength across the LSAG, ACG and DGG segments.
Splunk (SPLK) is expected to have recorded year-over-year higher revenues backed by positive demand trends.
Workday (WDAY) is likely to have recorded higher revenues in the fiscal first quarter driven by a healthy demand for its applications for finance and human resources.
SANTA CLARA, Calif., May 19, 2023--Agilent Technologies Inc. (NYSE: A), announced today the company intends to appeal the U.S. Patent and Trademarks Office (USPTO) Patent Trial and Appeal Board’s (PTAB) Final Written Decision in connection with the Inter Partes review (IPR) of U.S. Patent Nos. 10,337,001 & 10,900,034 (the Agilent Patents). The PTAB recently reversed the USPTO’s original decision granting claims directed towards chemically modified synthetic CRISPR guide RNA.
Vipshop's (VIPS) first-quarter results are expected to reflect strength in its merchandising strategy and discount retail business.
NVIDIA Corporation's (NVDA) Q1 performance is likely to reflect a continued recovery in the Gaming and Professional Visualization segments' revenues as inventory with channel partners reaches normal levels.
Agilent (A) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoom Video's (ZM) first-quarter performance is expected to have benefited from steady demand for its expanding portfolio like Zoom Video Webinars, Zoom Rooms and Zoom Phones.
SANTA CLARA, Calif., May 17, 2023--Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on July 26, 2023, to all shareholders of record as of the close of business on July 3, 2023.
Palo Alto's (PANW) fiscal Q3 revenues are expected to have benefited from the heightened demand for cybersecurity solutions.
Agilent Technologies (A) closed at $126.29 in the latest trading session, marking a -0.94% move from the prior day.
SANTA CLARA, Calif., May 16, 2023--Agilent Technologies Inc. (NYSE: A) today received a SEAL Business Sustainability Award for producing products and technology that are helping analytical and clinical labs reduce their carbon footprint.
Applied Materials' (AMAT) second-quarter fiscal 2023 results are expected to reflect strength in memory and ICAPS portfolio amid impacts of supply-chain constraints.
Jack Henry's (JKHY) is likely to expand its reach among financial institutions through FedNow Service, a real-time payments network.
Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Synopsys' (SNPS) Q2 performance is likely to have benefited from the increasing demand for advanced technology, design, IP and security solutions.
A stronger U.S. dollar, the business operation closure in Russia and divestitures over the past 12 months are likely to have negatively impacted DXC Technology's (DXC) fourth-quarter fiscal 2023 performance.